234 related articles for article (PubMed ID: 25473177)
1. MK-0626, a selective DPP-4 inhibitor, attenuates hepatic steatosis in ob/ob mice.
Ohyama T; Sato K; Yamazaki Y; Hashizume H; Horiguchi N; Kakizaki S; Mori M; Kusano M; Yamada M
World J Gastroenterol; 2014 Nov; 20(43):16227-35. PubMed ID: 25473177
[TBL] [Abstract][Full Text] [Related]
2. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
3. The Dipeptidyl Peptidase-4 Inhibitor Teneligliptin Attenuates Hepatic Lipogenesis via AMPK Activation in Non-Alcoholic Fatty Liver Disease Model Mice.
Ideta T; Shirakami Y; Miyazaki T; Kochi T; Sakai H; Moriwaki H; Shimizu M
Int J Mol Sci; 2015 Dec; 16(12):29207-18. PubMed ID: 26670228
[TBL] [Abstract][Full Text] [Related]
4. Green tea extract attenuates hepatic steatosis by decreasing adipose lipogenesis and enhancing hepatic antioxidant defenses in ob/ob mice.
Park HJ; DiNatale DA; Chung MY; Park YK; Lee JY; Koo SI; O'Connor M; Manautou JE; Bruno RS
J Nutr Biochem; 2011 Apr; 22(4):393-400. PubMed ID: 20655714
[TBL] [Abstract][Full Text] [Related]
5. Tangshen formula attenuates hepatic steatosis by inhibiting hepatic lipogenesis and augmenting fatty acid oxidation in db/db mice.
Kong Q; Zhang H; Zhao T; Zhang W; Yan M; Dong X; Li P
Int J Mol Med; 2016 Dec; 38(6):1715-1726. PubMed ID: 27840945
[TBL] [Abstract][Full Text] [Related]
6. Ping-tang Recipe () improves insulin resistance and attenuates hepatic steatosis in high-fat diet-induced obese rats.
Yang SY; Zhao NJ; Li XJ; Zhang HJ; Chen KJ; Li CD
Chin J Integr Med; 2012 Apr; 18(4):262-8. PubMed ID: 22457136
[TBL] [Abstract][Full Text] [Related]
7. Increased dietary fat contributes to dysregulation of the LKB1/AMPK pathway and increased damage in a mouse model of early-stage ethanol-mediated steatosis.
Shearn CT; Smathers RL; Jiang H; Orlicky DJ; Maclean KN; Petersen DR
J Nutr Biochem; 2013 Aug; 24(8):1436-45. PubMed ID: 23465594
[TBL] [Abstract][Full Text] [Related]
8. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
[TBL] [Abstract][Full Text] [Related]
9. A long-lasting dipeptidyl peptidase-4 inhibitor, teneligliptin, as a preventive drug for the development of hepatic steatosis in high-fructose diet-fed ob/ob mice.
Nakamura K; Fukunishi S; Yokohama K; Ohama H; Tsuchimoto Y; Asai A; Tsuda Y; Higuchi K
Int J Mol Med; 2017 Apr; 39(4):969-983. PubMed ID: 28260070
[TBL] [Abstract][Full Text] [Related]
10. A dipeptidyl peptidase-IV inhibitor improves hepatic steatosis and insulin resistance by AMPK-dependent and JNK-dependent inhibition of LECT2 expression.
Hwang HJ; Jung TW; Kim BH; Hong HC; Seo JA; Kim SG; Kim NH; Choi KM; Choi DS; Baik SH; Yoo HJ
Biochem Pharmacol; 2015 Nov; 98(1):157-66. PubMed ID: 26297911
[TBL] [Abstract][Full Text] [Related]
11. Prevention and treatment effect of evogliptin on hepatic steatosis in high-fat-fed animal models.
Kim MK; Chae YN; Ahn GJ; Shin CY; Choi SH; Yang EK; Sohn YS; Son MH
Arch Pharm Res; 2017 Feb; 40(2):268-281. PubMed ID: 27885461
[TBL] [Abstract][Full Text] [Related]
12. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
Morgan K; Uyuni A; Nandgiri G; Mao L; Castaneda L; Kathirvel E; French SW; Morgan TR
Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):843-54. PubMed ID: 18794597
[TBL] [Abstract][Full Text] [Related]
13. Diet-induced adipose tissue inflammation and liver steatosis are prevented by DPP-4 inhibition in diabetic mice.
Shirakawa J; Fujii H; Ohnuma K; Sato K; Ito Y; Kaji M; Sakamoto E; Koganei M; Sasaki H; Nagashima Y; Amo K; Aoki K; Morimoto C; Takeda E; Terauchi Y
Diabetes; 2011 Apr; 60(4):1246-57. PubMed ID: 21330637
[TBL] [Abstract][Full Text] [Related]
14. Effects of sitagliptin on nonalcoholic fatty liver disease in diet-induced obese rats.
Akaslan SB; Degertekin CK; Yilmaz G; Cakir N; Arslan M; Toruner FB
Metab Syndr Relat Disord; 2013 Aug; 11(4):243-50. PubMed ID: 23544853
[TBL] [Abstract][Full Text] [Related]
15. Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression.
Sekiya M; Yahagi N; Matsuzaka T; Najima Y; Nakakuki M; Nagai R; Ishibashi S; Osuga J; Yamada N; Shimano H
Hepatology; 2003 Dec; 38(6):1529-39. PubMed ID: 14647064
[TBL] [Abstract][Full Text] [Related]
16.
Lee HA; Cho JH; Afinanisa Q; An GH; Han JG; Kang HJ; Choi SH; Seong HA
Nutrients; 2020 Oct; 12(11):. PubMed ID: 33142995
[No Abstract] [Full Text] [Related]
17. Dietary camphene attenuates hepatic steatosis and insulin resistance in mice.
Kim S; Choi Y; Choi S; Choi Y; Park T
Obesity (Silver Spring); 2014 Feb; 22(2):408-17. PubMed ID: 23818423
[TBL] [Abstract][Full Text] [Related]
18. Yhhu981, a novel compound, stimulates fatty acid oxidation via the activation of AMPK and ameliorates lipid metabolism disorder in ob/ob mice.
Zeng HL; Huang SL; Xie FC; Zeng LM; Hu YH; Leng Y
Acta Pharmacol Sin; 2015 Mar; 36(3):343-52. PubMed ID: 25732571
[TBL] [Abstract][Full Text] [Related]
19. Licochalcone A regulates hepatic lipid metabolism through activation of AMP-activated protein kinase.
Quan HY; Kim SJ; Kim DY; Jo HK; Kim GW; Chung SH
Fitoterapia; 2013 Apr; 86():208-16. PubMed ID: 23500383
[TBL] [Abstract][Full Text] [Related]
20. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]